245 related articles for article (PubMed ID: 29626304)
1. Efficacy of the Gallbladder Cancer Predictive Risk Score Based on Pathological Findings: A Propensity Score-Matched Analysis.
Mochizuki T; Abe T; Amano H; Hanada K; Hattori M; Kobayashi T; Nakahara M; Ohdan H; Noriyuki T
Ann Surg Oncol; 2018 Jun; 25(6):1699-1708. PubMed ID: 29626304
[TBL] [Abstract][Full Text] [Related]
2. A Novel Pathology-Based Preoperative Risk Score to Predict Locoregional Residual and Distant Disease and Survival for Incidental Gallbladder Cancer: A 10-Institution Study from the U.S. Extrahepatic Biliary Malignancy Consortium.
Ethun CG; Postlewait LM; Le N; Pawlik TM; Buettner S; Poultsides G; Tran T; Idrees K; Isom CA; Fields RC; Jin LX; Weber SM; Salem A; Martin RC; Scoggins C; Shen P; Mogal HD; Schmidt C; Beal E; Hatzaras I; Shenoy R; Merchant N; Cardona K; Maithel SK
Ann Surg Oncol; 2017 May; 24(5):1343-1350. PubMed ID: 27812827
[TBL] [Abstract][Full Text] [Related]
3. Nomogram to predict overall survival after gallbladder cancer resection in China.
Bai Y; Liu ZS; Xiong JP; Xu WY; Lin JZ; Long JY; Miao F; Huang HC; Wan XS; Zhao HT
World J Gastroenterol; 2018 Dec; 24(45):5167-5178. PubMed ID: 30568393
[TBL] [Abstract][Full Text] [Related]
4. Managing the incidentally detected gallbladder cancer: algorithms and controversies.
Cavallaro A; Piccolo G; Di Vita M; Zanghì A; Cardì F; Di Mattia P; Barbera G; Borzì L; Panebianco V; Di Carlo I; Cavallaro M; Cappellani A
Int J Surg; 2014; 12 Suppl 2():S108-S119. PubMed ID: 25182380
[TBL] [Abstract][Full Text] [Related]
5. Elevation of CA19-9 and CEA is associated with a poor prognosis in patients with resectable gallbladder carcinoma.
Wen Z; Si A; Yang J; Yang P; Yang X; Liu H; Yan X; Li W; Zhang B
HPB (Oxford); 2017 Nov; 19(11):951-956. PubMed ID: 28750922
[TBL] [Abstract][Full Text] [Related]
6. Clinical value of preoperative CA19-9 levels in evaluating resectability of gallbladder carcinoma.
Liu F; Wang JK; Ma WJ; Yang Q; Hu HJ; Li FY
ANZ J Surg; 2019 Mar; 89(3):E76-E80. PubMed ID: 30306702
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of surgical resection for gallbladder carcinoma at a Japanese cancer institute.
Nanashima A; Tobinaga S; Abo T; Morisaki T; Uehara R; Takeshita H; Nonaka T; Hidaka S; Takeshima F; Ohnita K; Isomoto H; Kunizaki M; Sawai T; Nakao K; Nagayasu T
Hepatogastroenterology; 2012 Sep; 59(118):1717-21. PubMed ID: 22819898
[TBL] [Abstract][Full Text] [Related]
8. Incidental gallbladder cancer by the AFC-GBC-2009 Study Group.
Fuks D; Regimbeau JM; Le Treut YP; Bachellier P; Raventos A; Pruvot FR; Chiche L; Farges O
World J Surg; 2011 Aug; 35(8):1887-97. PubMed ID: 21547420
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value and risk stratification of residual disease in patients with incidental gallbladder cancer.
Ramos E; Lluis N; Llado L; Torras J; Busquets J; Rafecas A; Serrano T; Mils K; Leiva D; Fabregat J
World J Surg Oncol; 2020 Jan; 18(1):18. PubMed ID: 31980034
[TBL] [Abstract][Full Text] [Related]
10. Surgical Strategy for T2 Gallbladder Cancer According to Tumor Location.
Lee H; Choi DW; Park JY; Youn S; Kwon W; Heo JS; Choi SH; Jang KT
Ann Surg Oncol; 2015 Aug; 22(8):2779-86. PubMed ID: 25519930
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of combined preoperative fibrinogen and CA199 in gallbladder cancer patients.
Xu WY; Zhang HH; Yang XB; Bai Y; Lin JZ; Long JY; Xiong JP; Zhang JW; Sang XT; Zhao HT
World J Gastroenterol; 2018 Apr; 24(13):1451-1463. PubMed ID: 29632426
[TBL] [Abstract][Full Text] [Related]
12. Validation of the oncologic effect of hepatic resection for T2 gallbladder cancer: a retrospective study.
Cho JK; Lee W; Jang JY; Kim HG; Kim JM; Kwag SJ; Park JH; Kim JY; Park T; Jeong SH; Ju YT; Jung EJ; Lee YJ; Hong SC; Jeong CY
World J Surg Oncol; 2019 Jan; 17(1):8. PubMed ID: 30616645
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of two inflammation-based prognostic scores in patients with resectable gallbladder carcinoma.
Wu XS; Shi LB; Li ML; Ding Q; Weng H; Wu WG; Cao Y; Bao RF; Shu YJ; Ding QC; Mu JS; Gu J; Dong P; Liu YB
Ann Surg Oncol; 2014 Feb; 21(2):449-57. PubMed ID: 24081806
[TBL] [Abstract][Full Text] [Related]
14. Long-Term Outcomes and Prognostic Factors in Advanced Gallbladder Cancer: Focus on the Advanced T Stage.
Chen C; Geng Z; Shen H; Song H; Zhao Y; Zhang G; Li W; Ma L; Wang L
PLoS One; 2016; 11(11):e0166361. PubMed ID: 27846279
[TBL] [Abstract][Full Text] [Related]
15. The predictive value of systemic immune inflammation index for postoperative survival of gallbladder carcinoma patients.
Chen H; Huang Z; Sun B; Wang A; Wang Y; Shi H; Zheng T; Li T; Huang M; Fu W
J Surg Oncol; 2021 Jul; 124(1):59-66. PubMed ID: 33765331
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of neutrophil-lymphocyte ratio and carbohydrate antigen 19-9 in patients with gallbladder carcinoma.
Liu F; Hu HJ; Ma WJ; Yang Q; Wang JK; Li FY
Medicine (Baltimore); 2019 Feb; 98(8):e14550. PubMed ID: 30813165
[TBL] [Abstract][Full Text] [Related]
17. Carcinoma of the gallbladder: patterns of presentation, prognostic factors and survival rate. An 11-year single centre experience.
D'Hondt M; Lapointe R; Benamira Z; Pottel H; Plasse M; Letourneau R; Roy A; Dagenais M; Vandenbroucke-Menu F
Eur J Surg Oncol; 2013 Jun; 39(6):548-53. PubMed ID: 23522952
[TBL] [Abstract][Full Text] [Related]
18. Hepatectomy strategy for T2 gallbladder cancer between segment IVb and V resection and wedge resection: A propensity score-matched study.
Chen M; Cao J; Xiang Y; Ma X; Bai Y; Lai Q; Tong C; Ma Z; Topatana W; Hu J; Li S; Juengpanich S; Yu H; Cai X
Surgery; 2021 Jun; 169(6):1304-1311. PubMed ID: 33551070
[TBL] [Abstract][Full Text] [Related]
19. The prognosis after curative resection of gallbladder cancer with hilar invasion is similar to that of hilar cholangiocarcinoma.
Nasu Y; Tanaka E; Hirano S; Tsuchikawa T; Kato K; Matsumoto J; Shichinohe T; Kondo S
J Hepatobiliary Pancreat Sci; 2012 May; 19(3):274-80. PubMed ID: 21879321
[TBL] [Abstract][Full Text] [Related]
20. Survival prediction for gallbladder carcinoma after curative resection: Comparison of nomogram and Bayesian network models.
Wu Y; Li Q; Cai Z; Zhang Y; Qiu Y; Yang N; Song T; Li S; Lou J; Li J; Mao X; Chen C; Zhang D; Si S; Geng Z; Tang Z
Eur J Surg Oncol; 2020 Nov; 46(11):2106-2113. PubMed ID: 32807616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
